Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis
Conclusions: TACE combined with apatinib may result in superior OS compared to TACE therapy alone for HCC patients with macrovascular invasion.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Lujun Shen Shuanggang Chen Zhiyu Qiu Han Qi Hui Yuan Fei Cao Lin Xie Qifeng Chen Wang Li Weijun Fan Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Statistics | Study